C. For a covered individual who renews the same health care plan, a health care insurer, pharmacy benefit manager or utilization review agent shall approve a formulary exception for the covered individual if the covered individual has been previously approved to receive the nonformulary prescription drug under the same health care plan and the prescribing health care provider uses the formulary exception process and provides relevant clinical documentation to certify all of the following:

1. 1. The covered individual has tried a formulary equivalent prescription drug that was a part of the covered individual's prescription drug benefit at the time of the trial, the formulary equivalent prescription drug was not effective in the treatment of the covered individual's medical condition and the health care provider specifies the contraindication or adverse or harmful reaction in the covered individual.
2. 2. The covered individual has experienced a positive therapeutic outcome on the requested drug for more than ninety days.
3. 3. Formulary equivalent prescription drugs are contraindicated or will likely cause a serious adverse reaction.

D. If a covered individual does not qualify for a formulary exception pursuant to subsection C of this section, the covered individual may still apply for a formulary exception using the health care insurer's, pharmacy benefit manager's or utilization review agent's formulary exception process. When evaluating whether the covered individual should qualify for a formulary exception to continue on a nonformulary prescription drug, the health care insurer, pharmacy benefit manager or utilization review agent shall consider the following factors:

1. 1. Whether the covered individual has experienced a positive therapeutic outcome on the previously approved drug.

2. 2. Whether the formulary prescription drug is not in the best interest of the covered individual based on medical necessity because the covered individual's use of the formulary prescription drug is expected to cause either of the following:

   1. (a) A negative impact on the covered individual's comorbid condition.
   2. (b) A clinically predictable negative drug interaction.
3. 3. Whether the formulary prescription drug is contraindicated or will likely cause a serious adverse reaction.

G. This section does not:

1. 1. Prevent a health care provider from prescribing another prescription drug that is covered by the health care insurer or the pharmacy benefit manager if the health care provider deems the prescription drug medically necessary for the covered individual.

2. 2. Prevent a health care insurer or pharmacy benefit manager that is contracted to provide pharmacy benefit management services from managing its formulary in compliance with this section, including:

   1. (a) Adding a prescription drug to its formulary.
   2. (b) Removing a prescription drug from its formulary if the drug manufacturer has removed the prescription drug for sale in the United States.
   3. (c) Setting the cost sharing for nonformulary prescription drugs.

K. For the purposes of this section:

1. 1. "Exigent circumstances" means a covered individual is suffering from a health condition that may seriously jeopardize the covered individual's life, health or ability to regain maximum function or when a covered individual is undergoing a current course of treatment using a nonformulary prescription drug.
2. 2. "Formulary exception" means that health plan coverage of a health care provider's selected prescription drug is granted.
3. 3. "Health care insurer" has the same meaning prescribed in section 20-2501.
4. 4. "Health care plan" means a policy, contract or evidence of coverage that a health care insurer issues to an insured, enrollee or subscriber.
5. 5. "Utilization review agent" means a utilization review agent as defined in section 20-2530 that is contracted to provide pharmacy benefit management services for a health care insurer.